Furthermore, this study provides an effective strategy applicable for designing and engineering nanoscale multivalent drugs targeting other disease proteins, such as S in MERS-CoV, HA in influenza, Env in HIV, F protein in RSV, and TNF-α in cancer. This evidence concerns the gene ERVW-1 and cancer.